Athira Pharma, INC. 8-K/A Filing

Ticker: LONA · Form: 8-K/A · Filed: Dec 18, 2025 · CIK: 1620463

Sentiment: neutral

Filing Stats: 4,681 words · 19 min read · ~16 pages · Grade level 18.6 · Accepted 2025-12-18 08:24:52

Key Financial Figures

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. Private Placement Financing On December 18, 2025, Athira Pharma, Inc. (the " Company " or " Athira ") entered into a securities purchase agreement (the " PIPE Securities Purchase Agreement ") with a select group of investors, including Commodore Capital LP (" Commodore "), TCG Crossover Management LLC (" TGCX "), Perceptive Advisors (" Perceptive ") and other accredited investors, one of which is affiliated with a member of the board of directors (the " Board ") of the Company (collectively, the " PIPE Purchasers "), pursuant to which the PIPE Purchasers have agreed to purchase and the Company has agreed to issue and sell, by way of a private placement (the " Private Placement ") an aggregate of (a) 5,356,547 shares (the " PIPE Initial Shares ") of the Company's common stock, par value $0.0001 per share (the " Common Stock ") and (b) pre-funded warrants (the " PIPE Pre-Funded Warrants ") to purchase 8,816,684 shares of Common Stock (the " PIPE Pre-Funded Warrant Shares ") and (c) accompanying warrants (the " PIPE Series A Common Warrants ") to purchase 23,031,494 shares of Common Stock and/or shares underlying pre-funded warrants, representing 162.5% of the aggregate of PIPE Initial Shares and the shares of Common Stock underlying the PIPE Pre-Funded Warrants (the shares, or the shares issuable pursuant to such pre-funded warrants, the " PIPE Series A Common Warrant Shares ") and (d) accompanying warrants (the " PIPE Series B Common Warrants " and, together with the PIPE Series A Common Warrants and the PIPE Pre-Funded Warrants, the " PIPE Warrants ", and the PIPE Warrants, together with the PIPE Initial Shares, the " PIPE Securities ") to purchase 21,259,842 shares of Common Stock and/or shares underlying pre-funded warrants, representing 150% of the aggregate of PIPE Initial Shares and the shares of Common Stock underlying the PIPE Pre-Funded Warrants (the shares, or the shares issuable pursuant to such pre

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on Read The Filing